Force development during target-directed isometric force production in Parkinson's disease.
This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.
DOI: 10.1016/j.neulet.2006.11.009
Bibliographic record from the original reports
Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.
Park JH, Stelmach GE. Force development during target-directed isometric force production in Parkinson's disease. Neurosci Lett. 2007;412(2):173–8. DOI 10.1016/j.neulet.2006.11.009
Conditions: COND-PD Parkinson’s disease
Scoped audit evidence
These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.
Parkinson’s disease — strength
- access status: full_main_text_available
STR-33-01
Limitations: Only current scoped checks; archived captures not authenticated against live originals.
Parkinson’s disease strength
- current access: full_main_text_available
- primary version: PMC author manuscript
Parkinson’s disease strength component — Park target-force task
The abstract confirms 15/35/55% MVC targets, preferred/maximal speed conditions, reduced force-development rate and longer time to peak as amplitude increased.
Source locator: Primary abstract
Limitations: AI-assisted source comparison; no raw-data verification.
Reports citing this source
- Strength muscle power and rapid force production assessment in Parkinson’s disease · reference 33 · original reference
Update record
- 2026-10-03: Created from the supplied reports and final scoped audit. New evidence should be appended with source version, access date, exact locator and affected report links.
Updating the wiki · Evidence and status guide